TSS
TGTX icon

Two Sigma Securities’s TG Therapeutics TGTX Stock Holding History

Two Sigma Securities’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,100
Closed -$265K – 1706
2020
Q4 		$265K Buy
+5,100
New +$172K 0.01% 1138

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Securities's TGTX Position: Q1 2026 in Review

Two Sigma Securities opened a new position in TG Therapeutics (TGTX) in Q1 2026: 9,885 shares worth $328K. The stake represents 0.04% of the portfolio and ranks #715 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in TGTX as recently as Q3 2024.

Two Sigma Securities first reported a position in TGTX in Q1 2017 and has held it in 5 quarters since. The position peaked at $440K in Q4 2019. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Two Sigma Securities held 9,885 shares of TG Therapeutics worth $328K as of Q1 2026.
  • TG Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • TG Therapeutics made up 0.04% of Two Sigma Securities's portfolio in Q1 2026, its #715 holding.
  • Two Sigma Securities first reported a position in TG Therapeutics in Q1 2017 and has held it in 5 quarters since.
  • Two Sigma Securities's TG Therapeutics position peaked at $440K in Q4 2019.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.